Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,931 | 6,817 | -3,837 | -2,017 | -1,306 |
| Depreciation Amortization | 63 | 19 | 69 | 21 | 14 |
| Accounts payable and accrued liabilities | -1,157 | -620 | 789 | 244 | 172 |
| Other Working Capital | -1,293 | -1,106 | 1,145 | 425 | 420 |
| Other Operating Activity | -8,770 | -8,477 | 264 | 74 | -120 |
| Operating Cash Flow | $-8,226 | $-3,367 | $-1,570 | $-1,252 | $-820 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 29,107 | 29,107 | N/A | N/A | N/A |
| Investing Cash Flow | $29,107 | $29,107 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -16 | -11 | -7 |
| Common Stock Issued | N/A | 750 | 1,513 | 1,229 | 1,056 |
| Other Financing Activity | 750 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $750 | $750 | $1,497 | $1,219 | $1,049 |
| Beginning Cash Position | 104 | 104 | 176 | 176 | 176 |
| End Cash Position | 21,734 | 26,593 | 104 | 143 | 405 |
| Net Cash Flow | $21,631 | $26,489 | $-72 | $-33 | $229 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,226 | -3,367 | -1,570 | -1,252 | -820 |
| Free Cash Flow | -8,226 | -3,367 | -1,570 | -1,252 | -820 |